IMLFF : Summary for INMED PHARMACEUTICAL - Yahoo Finance

U.S. Markets close in 1 hr 53 mins

InMed Pharmaceuticals Inc. (IMLFF)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.29+0.00 (+1.66%)
As of 1:49PM EST. Market open.
People also watch
OGRMFSPRWFTURVCGRWCCAN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.29
Open0.30
Bid0.00 x
Ask0.00 x
Day's Range0.29 - 0.31
52 Week Range0.05 - 0.43
Volume856,569
Avg. Volume764,759
Market Cap25.92M
Beta4.03
PE Ratio (TTM)-11.76
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire8 hours ago

    InMed Receives over $1,350,000 From Warrant Exercise

    OTCQB: IMLFF), reported today that prior to their expiry on Friday, February 24, 2017 a total of 10,672,750 common share purchase warrants have been exercised at a price of $0.13 per common share. No commissions or placement fees have been paid related to the funds received from this warrant exercise. InMed is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.

  • CNW Group8 hours ago

    InMed Receives over $1,350,000 From Warrant Exercise

    InMed Receives over $1,350,000 From Warrant Exercise

  • Accesswire11 days ago

    InMed's Cannabis Pipeline, Financials and Prospects

    NEW YORK, NY / ACCESSWIRE / February 16, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies is covering InMed Pharmaceuticals ...